Catalyst Wire Dossier Catalyst Wire Dossier

Recombinant human LH add-on therapy

recombinant human luteinizing hormone
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant human LH add-on therapy, covering 2016-02-03 to 2016-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Observational Prospective Study of the Success of Single Embryo Transfer Implantation Related to Level of Follicular Fluid Cytokines Expression in Low Responders Infertile Patients Treated With r-hLH add-on Therapy in a Second Controlled Ovarian Stimulation Cycle.

See pricing